Wellington Management Group LLP 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Purchase | 2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 28,461,994 9.500% | 4,497,950 (+18.77%) | Filing |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 23,964,044 8.080% | 8,774,020 (+57.76%) | Filing |
| 2024-02-08 10:05 am Purchase | 2023-12-29 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 15,190,024 5.180% | 7,082,677 (+87.36%) | Filing |
| 2023-02-06 2:49 pm Sale | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 8,107,347 2.890% | -18,541,327 (-69.58%) | Filing |
| 2022-02-04 09:15 am Purchase | 2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | Wellington Management Group LLP | 26,648,674 9.560% | 26,648,674 (New Position) | Filing |